FOSAMAX NEWS: FDA Panel Scheduled to Review Safety of Fosamax and Other Bisphosphonates
The U.S. Food and Drug Administration (“FDA”) announced that an advisory panel will convene on September 9, 2011 to discuss the side effects and risks associated with prolonged use of bisphosphonate drugs, such as Fosamax, Boniva, Actonel and Reclast. Bisphosphonates, such as Fosamax, are commonly prescribed for the treatment of osteoporosis. Currently, an estimated 5 million Americans use bisphosphonates. However, these medications have recently been the subject of widespread criticism because numerous studies have shown that they put users at an increased risk for sustaining dangerous side effects, such as atypical femur fractures and osteonecrosis of the jaw (“ONJ”). The panel, which will consist of outside advisors to the FDA, will evaluate whether the risks of femur fractures and ONJ are due to long term bisphosphonate use, and whether a recommended duration for bisphosphonate use is warranted.
- Fosamax And Femur Fractures: A Close Look At An Important New Study
- Fosamax Side Effects
- Fosamax Jaw Deterioration
- Fosamax Femur Fracture
- Fosamax Heart Condition
- Fosamax Warnings
- Fosamax Lawsuit
- Fosamax Lawyer
- Fosamax Jaw
- Fosamax Warning
- Fosamax Femur Fracture Lawsuit
- Fosamax Lawsuits
- Fosamax Attorney
- Fosamax Femur Fractures
- Fosamax Injuries
- Fosamax Side Effects: Femur Fractures and Jaw Disease
Dangerous Drug Alert
Prior FDA Warning Regarding Fosamax Femur Fractures
This latest announcement is part of the FDA’s ongoing safety review of bisphosphonate use. In October 2010, the FDA required bisphosphonate manufacturers to change the labeling on drugs such as Fosamax in order to warn consumers of the increased risk of sustaining femur fractures. Specifically, the FDA warned that those who use Fosamax and other bisphosphonates should be mindful of the possible risk of sustaining an atypical femur fracture when using the drug for longer than five years. In addition to changing the labeling, the FDA encouraged patients to report any adverse side effects, as well as seek medical attention if they experience any pain in the groin or thigh area while using a bisphosphonate.
Currently, Merck, the manufacturer of Fosamax, is defending hundreds of lawsuits filed by victims who were injured as a result of their Fosamax use. The Fosamax lawsuits allege that Merck failed to adequately research and warn consumers of the dangerous side effects of Fosamax.
Fosamax Femur Fracture Lawsuits
If you or a loved one sustained an atypical femur fracture as a result of Fosamax use, you may be able to file a Fosamax femur fracture lawsuit seeking compensation for your medical expenses, pain and suffering, lost wages and more. Contact one of our Fosamax femur fracture lawyers today for a free and confidential evaluation. The lawyers at Bernstein Liebhard LLP have extensive litigation experience, and have recovered billions of dollars for their clients. In addition to being staunch advocates for your claim, our Fosamax injury lawyers also provide personal attention to guide you through the complex litigation process.